You searched for "device"

1496 results found

UK clinics providing Lenire tinnitus treatment device double in latest expansion

Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device. Tinnitus, which is commonly known as “ringing in...

Development of a new negative-pressure ventilatory support device: Exovent

The pandemic has driven innovation in ways that we have not seen for many decades. Intensive care medicine and ENT have been at the forefront of these advances, and our good friends David Howard (never one to put his feet...

Smart cochlear device: how biosensors could revolutionise hearing care

Smart cochlear implants could monitor inner ear health, deliver drugs and adapt in real time, merging biosensing, microfluidics and personalised hearing care. From passive hearing aids to smart implants Hearing technology has advanced dramatically over the last few decades, yet...

KARL STORZ Gains Approval for Solo+™ Revolutionary Ear Tube Placement Device

Chronic ear infections are a leading reason for doctor visits and surgical procedures such as placement of ear tubes in young children.

Hearing preservation and device benefit following implantation of short or hybrid electrodes

Hybrid or short electrodes have increasingly been used in the literature in order to combine electrical with hearing-aid stimulation. However, hearing preservation of the residual low-frequencies are of utmost importance in this attempt. The present study compared hearing preservation and...

Bone bridge conduction device for patients with bilateral microtia-atresia

Management of microtia-atresia requires a multidisciplinary approach. Children normally require bone conduction hearing aid devices very early in life to improve and facilitate speech and language development. At a later stage, when the cranial bones have strengthened and become thicker,...

FDA grants Lenire tinnitus treatment device De Novo approval

Neuromod Devices Ltd. is proud to announce that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire.

Increasing tongue strength to reduce dysphagia: what is the potential benefit of a device driven exercise?

Weakness in tongue muscle strength and laryngeal elevation is known to have an adverse impact on swallowing function. Various swallowing exercises are often recommended to improve function of these important structures with the goal of preventing aspiration and improving swallow...

Neuromod expands availability of Lenire tinnitus treatment device in Europe with 19 new clinical partnerships

Neuromod Devices, the technology company that specialises in medical devices for tinnitus treatment, has announced 19 new clinical partnerships to expand the availability of the Lenire tinnitus treatment device in Europe. This latest expansion will significantly increase the number of...

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.

Meet the Johns Hopkins team developing a 3D-printed device allowing COVID-19 patients to share ventilators

    Amid a shortage of ventilators, the team of engineers and clinicians came together to create an open-source ventilator splitter that hospitals and communities can produce. CLICK HERE

Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device

Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...